I really wonder why the "Newer Hpoglycemic agent",especially Liraglutide of the GLP1 type & Pramlintide of Amylin Analogue type aren't available here in India,other than Sitagliptin of DPP4 type for treatment of Diabetes,which will make it easier to keep the Blood Glucose Levels under control,thus preventing development of complications,apart from increasing the Patient Compliance.